|
Hier mal was neues von Jinxin zu EVT 201: May 23, 2019, 09:03, ask the Secretary of the Board of Directors Investor questions: EVT201 capsule, how long does it take for this medicine to go from the third phase of clinical trial? Secretary secret answer ( Jingxin Pharmaceutical) (10.400, -0.21, -1.98%) Sz002020): Currently in the second phase of the summary, it is expected to enter the third phase this year. Thank you Asked at the Secretary of the Board of Directors at 08:45 on November 4, 2019 Investor questions: How is the progress of the company's EVT201, whether it enters the third phase of clinical Secretary secret answer ( Jingxin Pharmaceutical) (10.400, -0.21, -1.98%) SZ002020): The company's EVT201 has completed Phase II clinical trials and is about to enter Phase III clinical trials. Thank you! |
|
| aus der Diskussion: | Evotec 566480, wohin geht die Reise??? |
| Autor (Datum des Eintrages): | freiwilder (21.11.19 10:41:40) |
| Beitrag: | 58,519 von 82,051 (ID:61980014) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |